FGHQF
Price
$0.15
Change
+$0.05 (+50.00%)
Updated
Jul 31 closing price
Capitalization
284.39M
Intraday Buy/Sell Signals
ZVRA
Price
$10.71
Change
+$0.10 (+0.94%)
Updated
Oct 27, 11:54 AM (EDT)
Capitalization
595.59M
9 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

FGHQF vs ZVRA

Header iconFGHQF vs ZVRA Comparison
Open Charts FGHQF vs ZVRABanner chart's image
Frontage
Price$0.15
Change+$0.05 (+50.00%)
Volume$130
Capitalization284.39M
Zevra Therapeutics
Price$10.71
Change+$0.10 (+0.94%)
Volume$300
Capitalization595.59M
FGHQF vs ZVRA Comparison Chart in %
ZVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FGHQF vs. ZVRA commentary
Oct 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGHQF is a Hold and ZVRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 27, 2025
Stock price -- (FGHQF: $0.15 vs. ZVRA: $10.61)
Brand notoriety: FGHQF and ZVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FGHQF: 100% vs. ZVRA: 37%
Market capitalization -- FGHQF: $284.39M vs. ZVRA: $595.59M
FGHQF [@Biotechnology] is valued at $284.39M. ZVRA’s [@Biotechnology] market capitalization is $595.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $108.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FGHQF’s FA Score shows that 0 FA rating(s) are green whileZVRA’s FA Score has 1 green FA rating(s).

  • FGHQF’s FA Score: 0 green, 5 red.
  • ZVRA’s FA Score: 1 green, 4 red.
According to our system of comparison, ZVRA is a better buy in the long-term than FGHQF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ZVRA’s TA Score shows that 5 TA indicator(s) are bullish.

  • ZVRA’s TA Score: 5 bullish, 5 bearish.

Price Growth

FGHQF (@Biotechnology) experienced а 0.00% price change this week, while ZVRA (@Biotechnology) price change was -1.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.97%. For the same industry, the average monthly price growth was +11.13%, and the average quarterly price growth was +63.98%.

Reported Earning Dates

ZVRA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+0.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZVRA($596M) has a higher market cap than FGHQF($284M). FGHQF YTD gains are higher at: 48.317 vs. ZVRA (27.218).
FGHQFZVRAFGHQF / ZVRA
Capitalization284M596M48%
EBITDAN/A36.4M-
Gain YTD48.31727.218178%
P/E Ratio78.84N/A-
RevenueN/A62M-
Total CashN/A203M-
Total DebtN/A62.3M-
FUNDAMENTALS RATINGS
ZVRA: Fundamental Ratings
ZVRA
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
88
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
22
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FGHQFZVRA
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
84%
Stochastic
ODDS (%)
N/A
Bullish Trend 4 days ago
78%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
82%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
4%
Bearish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
4%
Bullish Trend 4 days ago
78%
Advances
ODDS (%)
N/A
Bullish Trend 18 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
77%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
81%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ZVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AILLX30.050.23
+0.77%
Aristotle Core Equity I-2
FBTAX34.920.10
+0.29%
Fidelity Advisor Biotechnology A
NOINX17.700.03
+0.17%
Northern International Equity Index
LHCAX20.99-0.01
-0.05%
Lord Abbett Health Care A
EPVIX13.75-0.11
-0.79%
EuroPac International Value I

FGHQF and

Correlation & Price change

A.I.dvisor tells us that FGHQF and ANL have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FGHQF and ANL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FGHQF
1D Price
Change %
FGHQF100%
N/A
ANL - FGHQF
25%
Poorly correlated
-0.49%
SKYE - FGHQF
15%
Poorly correlated
+6.21%
LEXX - FGHQF
9%
Poorly correlated
+2.04%
HMTXF - FGHQF
8%
Poorly correlated
N/A
ZVRA - FGHQF
4%
Poorly correlated
-0.66%
More

ZVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZVRA has been loosely correlated with COGT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ZVRA jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZVRA
1D Price
Change %
ZVRA100%
-0.66%
COGT - ZVRA
39%
Loosely correlated
+1.95%
IMTX - ZVRA
39%
Loosely correlated
N/A
ACLX - ZVRA
38%
Loosely correlated
+0.73%
AUTL - ZVRA
36%
Loosely correlated
+2.00%
FULC - ZVRA
36%
Loosely correlated
+3.02%
More